Closing Gender-Based Disease Disparities Starts in the Lab Women must have a seat at the table in deciding what type of research to pursue Apr 27, 2024
Alzheimer's Drug Skepticism; Safeguarding Brain Data; Benefits of Stimulating Jobs News and commentary from the world of neurology and neuroscience Apr 23, 2024
Novel Drug Made of Gold Nanocrystals Appears Safe in Multiple Sclerosis Small study suggested benefits for MS patients with chronic optic neuropathy Apr 22, 2024
Multiple Sclerosis Predicted by Autoantibody Signature Blood samples reveal signs of MS years before clinical diagnosis Apr 19, 2024
Ocrelizumab Trial Fills Research Gap for Black, Hispanic MS Patients Half of patients had no evidence of disease activity at 48 weeks Apr 18, 2024
The Dying Brain; Obesity Drugs and MS; NurOwn Tries Again News and commentary from the world of neurology and neuroscience Apr 09, 2024
Caffeine and Parkinson's; Brutally Honest Look at Dementia; Three MS Subtypes News and commentary from the world of neurology and neuroscience Apr 02, 2024
Stopping High-Efficacy MS Drugs Raises Relapse Risk for Older Patients Discontinuing natalizumab and fingolimod carried highest risk Mar 27, 2024
Epstein-Barr and MS; When Lewy Pathology Starts; Alzheimer's Blood Test Assessed News and commentary from the world of neurology and neuroscience Mar 19, 2024
Viagra and Alzheimer's; Migraine Consensus Statement; FDA Updates Drug Guidance News and commentary from the world of neurology and neuroscience Mar 12, 2024
Breastfeeding While Taking MS Monoclonal Antibody Drugs Appears Safe No negative effects on early infant development or health seen Mar 11, 2024
BTK Inhibitor Fails to Eliminate Paramagnetic Rim Lesions in MS Higher tolebrutinib dose, longer treatment duration may be needed Mar 07, 2024
Evobrutinib Fails to Beat Teriflunomide in Relapsing MS No efficacy difference between the two drugs in two phase III trials Mar 06, 2024
Lucid Moments in Late Dementia; Seizure Dogs and Epilepsy; Wildfire Smoke Effects News and commentary from the world of neurology and neuroscience Mar 05, 2024
Cognitive Decline in MS Predicted by Paramagnetic Rim Lesions Processing speed scores lower 4 years later for people with one or more baseline lesions Mar 04, 2024
Ozanimod Controls MS Disease Activity Regardless of Age Clinical, radiologic measures remained stable or improved in both younger and older patients Mar 03, 2024
Long COVID May Be Difficult to Identify in MS Tough to pinpoint what is a long-term MS symptom and what is a long COVID symptom Mar 02, 2024
Obesity Associated With Faster MS Disease Progression Increased risk of physical, psychological, cognitive decline Mar 02, 2024
Leaky Blood Vessels and Long COVID; BCG Vaccine and Alzheimer's; New CTE Subtype News and commentary from the world of neurology and neuroscience Feb 27, 2024
Herpes-Dementia Link; How COVID Affects the Brain; FDA to Decide on Duchenne Drug News and commentary from the world of neurology and neuroscience Feb 20, 2024
Highly Effective Therapies Early in Pediatric MS Linked to Reduced Relapse Risk Study supports starting kids on high-efficacy drugs, but long-term safety studies are crucial Feb 16, 2024
Novel Anti-CD40L Antibody Slows New Brain Lesions in Relapsing MS Frexalimab shows promise in phase II study Feb 14, 2024
When Does Brain Death Occur? Parkinson's-Paraquat Links; AI Boosts ARIA Detection News and commentary from the world of neurology and neuroscience Feb 13, 2024
Can the Eye Reveal Cardiac and Lung Disease -- Plus Much More? Researchers link thinner retinal layers to higher risk of multiple diseases Jan 26, 2024
Unusual Visual Symptoms and Alzheimer's; Infections and Dementia; Head Trauma and MS News and commentary from the world of neurology and neuroscience Jan 23, 2024
What Super-Agers Show; Epstein-Barr and Early MS; Five Variants of Alzheimer's News and commentary from the world of neurology and neuroscience Jan 09, 2024
Neurologic Disabilities Linked to Long COVID Risks Certain persistent symptoms more likely compared with other COVID patients Jan 04, 2024
Midlife Alzheimer's Biomarker; How Measles Spread in the Brain; MS and HIV News and commentary from the world of neurology and neuroscience Dec 26, 2023
Ozanimod Did Not Appear to Lead to More Adverse Pregnancy Outcomes However, avoiding pregnancy when on the IBD/MS drug still advised Dec 19, 2023
Twins and Dementia; CRISPR and Alzheimer's; BTK Inhibitor Fails in MS Trials News and commentary from the world of neurology and neuroscience Dec 12, 2023
Personality Predictors of Dementia; Parkinson's Blood Test; Klotho in Alzheimer's News and commentary from the world of neurology and neuroscience Dec 05, 2023
Progression Independent of Relapse Activity in Pediatric-Onset MS Early treatment with disease-modifying therapy may offer some protection Nov 29, 2023
Alzheimer's Vaccines Are Back; Streamlining Prior Authorization; Rare APOE Variant News and commentary from the world of neurology and neuroscience Nov 21, 2023
Developing a Consensus on Smoldering MS Experts aim to develop a deeper understanding of what smoldering disease entails Nov 21, 2023
High NfL Levels Predict Greater MS Disability Within 2 Years Temporal relationship is a critical insight, says Ahmed Abdelhak, MD Nov 20, 2023
A Novel Mechanism of Action in Treating Relapsing MS Our panel of experts discuss frexalimab Nov 17, 2023 video
Handheld Device Detects Alzheimer's Biomarkers; Long COVID Smell Loss; MS Fatigue News and commentary from the world of neurology and neuroscience Nov 14, 2023
New Data on CD40 Ligand Inhibitor for Relapsing MS Novel agent led to sustained reduction of new lesions at 24 weeks Nov 14, 2023 video
Should MS Patients Stop Treatment as They Age? Enrique Alvarez, MD, PhD discusses the challenges of deciding whether patients can safely quit Nov 13, 2023 video
